As a more proximal step in the cell response to doxorubicin toxicity, p53 overexpression plays a major role in developing dilatative cardiomyopathy and chronic kidney disease [11] mainly through its’ genomic integrity monitoring activity [62]. Here, TP53 is linked to chronic kidney disease.